Integra Lifesciences Holdings (IART) Operating Expenses (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Operating Expenses of $399.5 million for Q2 2026, up 5.0% sequentially from $380.4 million in Q1 2026, and down 56.97% YoY from $928.3 million in Q2 2025.
Integra Lifesciences Holdings (IART) Operating Expenses (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Operating Expenses for 18 years, with the latest figure at $399.5 million in Q2 2026.
- Quarterly Operating Expenses fell 56.97% year-over-year to $399.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 25.46% YoY) and the FY2025 annual result came in at $2.1 billion, up 34.54% from the prior year.
- Operating Expenses rose to $399.5 million in Q2 2026 per IART's latest filing, from $380.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $928.3 million in Q2 2025 and troughed at $320.1 million in Q3 2022.
- A 5-year average of $402.2 million and a median of $374.6 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses jumped 120.39% in 2025, then tumbled 56.97% in 2026.
- Over 5 years, Operating Expenses stood at $330.2 million in 2022, then advanced by 9.33% to $361.0 million in 2023, then gained by 12.75% to $407.0 million in 2024, then grew by 1.2% to $411.9 million in 2025, then declined by 3.01% to $399.5 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $399.5 million, $380.4 million, and $411.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 399.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 399.48 Mn |
| Mar 31, 2026 | 380.45 Mn |
| Dec 31, 2025 | 411.89 Mn |
| Sep 30, 2025 | 390.30 Mn |
| Jun 30, 2025 | 928.28 Mn |
| Mar 31, 2025 | 398.15 Mn |
| Dec 31, 2024 | 407.02 Mn |
| Sep 30, 2024 | 388.98 Mn |
| Jun 30, 2024 | 421.20 Mn |
| Mar 31, 2024 | 364.91 Mn |
| Dec 31, 2023 | 360.99 Mn |
| Sep 30, 2023 | 355.83 Mn |
| Jun 30, 2023 | 368.76 Mn |
| Mar 31, 2023 | 344.46 Mn |
| Dec 31, 2022 | 330.18 Mn |
| Sep 30, 2022 | 320.14 Mn |
| Jun 30, 2022 | 337.95 Mn |
| Mar 31, 2022 | 330.47 Mn |
| Dec 31, 2021 | 347.30 Mn |
| Sep 30, 2021 | 330.42 Mn |